The U.S. Food and Drug Administration has approved Entresto tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related ...

In addition, improvements in physical and social activities were observed at the pre-specified 8 months and continued through 3 years. Novartis announced findings ...

A US federal judge rejected Swiss drugmaker Novartis' request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of the blockbuster heart medication Entresto. In a ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Novartis A.G. (NYSE: NVS) is getting ready to steal a lot ...

Decision brings hope of longer and better life with fewer hospitalizations for millions of Europeans with symptomatic chronic heart failure with reduced ejection fraction · Entresto is the first and ...